Clearside Biomedical, Inc. is a clinical-stage biopharmaceutical company specializing in the development of innovative ophthalmic therapies. With a focus on treating serious eye diseases, the company utilizes a proprietary microinjector to deliver therapeutics to the back of the eye, improving the efficacy and safety of treatment options.
Notification